Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / South Korea

Boehringer Ingelheim Outpaces OTC Competitors

August 2008 | Company Finance Alert

Boehringer Ingleheim is outpacing the South Korean over-the-counter (OTC) medicine sector. The German company's sales increased 1.9% in the first half of 2008, while most other competitors experienced a downturn in revenue. Growth in South Korean OTC sales also exceeded that posted by Boehringer Ingleheim's global consumer healthcare division (+1.6%). BMI believes that one of the key reasons behind this strong performance is firm's enlightened marketing

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>